Published guidance, NICE advice and quality standards

Showing 571 to 580 of 784

Sort by

Published guidance, NICE advice and quality standards
Title	Reference number	Published	Last updated
Alirocumab for treating primary hypercholesterolaemia and mixed dyslipidaemia	TA393	22 June 2016	22 June 2016
Evolocumab for treating primary hypercholesterolaemia and mixed dyslipidaemia	TA394	22 June 2016	22 June 2016
Ceritinib for previously treated anaplastic lymphoma kinase positive non-small-cell lung cancer	TA395	22 June 2016	22 June 2016
Trametinib in combination with dabrafenib for treating unresectable or metastatic melanoma	TA396	22 June 2016	22 June 2016
Adalimumab for treating moderate to severe hidradenitis suppurativa	TA392	22 June 2016	22 June 2016
Canagliflozin, dapagliflozin and empagliflozin as monotherapies for treating type 2 diabetes	TA390	25 May 2016	25 May 2016
Sacubitril valsartan for treating symptomatic chronic heart failure with reduced ejection fraction	TA388	27 April 2016	27 April 2016
Topotecan, pegylated liposomal doxorubicin hydrochloride, paclitaxel, trabectedin and gemcitabine for treating recurrent ovarian cancer	TA389	27 April 2016	27 April 2016
Ruxolitinib for treating disease-related splenomegaly or symptoms in adults with myelofibrosis	TA386	23 March 2016	23 March 2016
Guidance on the use of temozolomide for the treatment of recurrent malignant glioma (brain cancer)	TA23	26 April 2001	3 March 2016